| Lastest Insider Transactions Of Aurinia Pharmaceuticals Inc. ( AUPH ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | Chief Legal Officer | 2026-08-21 | Sell | 20,975 | 16.97 | 355,946 | 2026-08-25 21:29:28 |
| AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Chief Executive Officer 10% Owner | 2026-05-29 | Buy | 814,606 | 15.29 | 12,455,227 | 2026-06-02 21:54:36 |
| AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Directior | 2026-02-27 | Buy | 900,000 | 14.10 | 12,688,806 | 2026-03-03 17:35:12 |
| AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Directior | 2025-08-01 | Buy | 1,300,000 | 10.45 | 13,590,000 | 2025-08-05 17:31:03 |
| AUPH | Aurinia Pharmaceuticals Inc. | Keenan Greg | Chief Medical Officer | 2025-08-01 | Sell | 20,000 | 10.50 | 210,000 | 2025-08-05 16:07:28 |
| AUPH | Aurinia Pharmaceuticals Inc. | Keenan Greg | Chief Medical Officer | 2025-03-07 | Sell | 8,305 | 8.23 | 68,350 | 2025-03-07 17:25:05 |
| AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | Chief Executive Officer | 2025-02-28 | Sell | 360,540 | 7.96 | 2,871,124 | 2025-03-04 21:02:08 |
| AUPH | Aurinia Pharmaceuticals Inc. | Keenan Greg | Chief Medical Officer | 2025-02-28 | Sell | 12,239 | 8.00 | 97,912 | 2025-03-04 20:59:49 |
| AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Chief Financial Officer | 2025-02-28 | Sell | 118,013 | 7.96 | 939,612 | 2025-03-04 20:58:10 |
| AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, General Counsel | 2025-02-28 | Sell | 122,479 | 7.96 | 975,223 | 2025-03-04 20:57:21 |
| AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | Chief Operating Officer | 2025-02-28 | Sell | 124,893 | 7.96 | 994,425 | 2025-03-04 20:56:40 |
| AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Directior | 2025-02-28 | Buy | 1,600,000 | 7.95 | 12,713,126 | 2025-03-04 17:03:02 |
| AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Directior | 2024-12-05 | Buy | 1,200,000 | 9.02 | 10,822,000 | 2024-12-09 16:52:50 |
| AUPH | Aurinia Pharmaceuticals Inc. | Bailey Jeffrey Allen | Directior | 2024-11-08 | Sell | 4,557 | 8.43 | 38,416 | 2024-11-12 19:29:43 |
| AUPH | Aurinia Pharmaceuticals Inc. | Bailey Jeffrey Allen | Directior | 2024-11-08 | Option Exercise | 17,913 | 0.00 | 0 | 2024-11-12 19:29:43 |
| AUPH | Aurinia Pharmaceuticals Inc. | Smith Karen L. | Directior | 2024-11-08 | Sell | 5,241 | 8.43 | 44,182 | 2024-11-12 19:20:36 |
| AUPH | Aurinia Pharmaceuticals Inc. | Smith Karen L. | Directior | 2024-11-08 | Option Exercise | 17,913 | 0.00 | 0 | 2024-11-12 19:20:36 |
| AUPH | Aurinia Pharmaceuticals Inc. | Balakrishnan Brinda | Directior | 2024-05-21 | Sell | 520 | 5.74 | 2,985 | 2024-05-22 16:16:53 |
| AUPH | Aurinia Pharmaceuticals Inc. | Billen Daniel | Directior | 2024-05-21 | Sell | 5,252 | 5.74 | 30,146 | 2024-05-22 16:14:25 |
| AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Directior | 2024-05-21 | Sell | 4,946 | 5.74 | 28,390 | 2024-05-22 16:11:31 |
| AUPH | Aurinia Pharmaceuticals Inc. | Leversage Jill | Directior | 2024-05-21 | Sell | 5,610 | 5.74 | 32,201 | 2024-05-22 16:09:46 |
| AUPH | Aurinia Pharmaceuticals Inc. | MacKay-Dunn R. Hector | Directior | 2024-05-21 | Sell | 5,630 | 5.74 | 32,316 | 2024-05-22 16:07:15 |
| AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | Chief Executive Officer | 2024-03-06 | Sell | 126,981 | 5.60 | 711,094 | 2024-03-07 16:46:19 |
| AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Chief Financial Officer | 2024-03-06 | Sell | 34,811 | 5.60 | 194,942 | 2024-03-07 16:44:49 |
| AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | EVP, Ops & Strategy | 2024-03-06 | Sell | 40,665 | 5.51 | 224,064 | 2024-03-07 16:43:47 |
| AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Chief Commercial Officer | 2024-03-06 | Sell | 17,777 | 5.60 | 99,551 | 2024-03-07 16:42:46 |
| AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, General Counsel | 2024-03-06 | Sell | 57,745 | 5.60 | 323,372 | 2024-03-07 16:41:59 |
| AUPH | Aurinia Pharmaceuticals Inc. | Knappertz Volker | EVP, Research and Development | 2024-02-27 | Sell | 4,930 | 6.10 | 30,073 | 2024-02-29 16:11:11 |
| AUPH | Aurinia Pharmaceuticals Inc. | Knappertz Volker | EVP, Research and Development | 2024-02-20 | Sell | 25,146 | 5.48 | 137,800 | 2024-02-22 16:35:13 |
| AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Chief Commercial Officer | 2024-02-20 | Sell | 15,867 | 5.48 | 86,951 | 2024-02-22 16:33:06 |
| AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, General Counsel | 2023-03-02 | Sell | 19,644 | 8.78 | 172,474 | 2024-02-22 16:19:43 |
| AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Chief Financial Officer | 2023-03-02 | Sell | 11,398 | 8.78 | 100,074 | 2024-02-22 16:17:28 |
| AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | Chief Executive Officer | 2023-03-02 | Sell | 33,047 | 8.78 | 290,153 | 2024-02-22 16:15:26 |
| AUPH | Aurinia Pharmaceuticals Inc. | Balakrishnan Brinda | Directior | 2023-05-18 | Option Exercise | 8,733 | 0.00 | 0 | 2023-05-23 17:22:34 |
| AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Directior | 2023-05-18 | Sell | 8,733 | 11.26 | 98,334 | 2023-05-23 17:19:49 |
| AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Directior | 2023-05-18 | Option Exercise | 8,733 | 0.00 | 0 | 2023-05-23 17:19:49 |
| AUPH | Aurinia Pharmaceuticals Inc. | Hagan Joseph P | Directior | 2023-05-18 | Sell | 272 | 10.58 | 2,878 | 2023-05-23 17:18:43 |
| AUPH | Aurinia Pharmaceuticals Inc. | Hagan Joseph P | Directior | 2023-05-18 | Option Exercise | 8,733 | 0.00 | 0 | 2023-05-23 17:18:43 |
| AUPH | Aurinia Pharmaceuticals Inc. | Billen Daniel | Directior | 2023-05-18 | Sell | 4,650 | 11.26 | 52,359 | 2023-05-23 17:17:48 |
| AUPH | Aurinia Pharmaceuticals Inc. | Billen Daniel | Directior | 2023-05-18 | Option Exercise | 8,733 | 0.00 | 0 | 2023-05-23 17:17:48 |
| AUPH | Aurinia Pharmaceuticals Inc. | MILNE GEORGE M JR | Directior | 2023-05-18 | Option Exercise | 8,733 | 0.00 | 0 | 2023-05-23 17:16:50 |
| AUPH | Aurinia Pharmaceuticals Inc. | MacKay-Dunn R. Hector | Directior | 2023-05-18 | Sell | 4,818 | 11.26 | 54,251 | 2023-05-23 17:16:00 |
| AUPH | Aurinia Pharmaceuticals Inc. | MacKay-Dunn R. Hector | Directior | 2023-05-18 | Option Exercise | 8,733 | 0.00 | 0 | 2023-05-23 17:16:00 |
| AUPH | Aurinia Pharmaceuticals Inc. | Leversage Jill | Directior | 2023-05-18 | Sell | 4,815 | 11.26 | 54,217 | 2023-05-23 17:14:54 |
| AUPH | Aurinia Pharmaceuticals Inc. | Leversage Jill | Directior | 2023-05-18 | Option Exercise | 8,733 | 0.00 | 0 | 2023-05-23 17:14:54 |
| AUPH | Aurinia Pharmaceuticals Inc. | MILNE GEORGE M JR | Directior | 2023-03-02 | Buy | 20,000 | 8.91 | 178,284 | 2023-03-06 16:29:53 |
| AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Chief Financial Officer | 2023-03-02 | Sell | 11,296 | 8.94 | 100,986 | 2023-03-06 16:29:20 |
| AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | EVP, General Counsel | 2023-03-02 | Sell | 19,402 | 8.94 | 173,454 | 2023-03-06 16:29:06 |
| AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | Chief Executive Officer | 2023-03-02 | Sell | 32,750 | 8.94 | 292,785 | 2023-03-06 16:27:56 |
